ArticleMedicine2026
Construction of a prognostic model using lactylation-related genes for predicting the prognosis of glioma patients.
Article in Medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Gliomas are the most lethal malignant tumors of the central nervous system, and their treatment continues to face serious challenges. Increasing evidence suggests that lactylation is strongly associated with tumorigenesis and progression. However, studies of lactylation in gliomas are rare. In this study, we screened for lactylation-related genes in glioblastoma affecting patient prognosis based on TCGA and GEO databases and constructed a prediction model for lactylation-related genes using various machine learning methods. In addition, the researchers have also performed tumor somatic mutation difference analysis, drug sensitivity analysis, and single-cell analysis. We developed a prognostic model for lactylation-related genes and validated its predictive power. Further analysis revealed differences in tumor somatic mutations between the high- and low-risk groups. We screened 50 drugs using drug sensitivity analysis, and at the single-cell level, we demonstrated the expression of characterized genes in glioblastoma. Our findings suggest that the lactylation-related gene prediction model can serve as a reliable tool for predicting the prognosis of patients with glioma.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.